BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 11001535)

  • 1. Glycopeptide resistance in enterococci.
    Méndez-Alvarez S; Pérez-Hernández X; Claverie-Martín F
    Int Microbiol; 2000 Jun; 3(2):71-80. PubMed ID: 11001535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycopeptide-resistant enterococci: a decade of experience.
    Woodford N
    J Med Microbiol; 1998 Oct; 47(10):849-62. PubMed ID: 9788808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired and intrinsic glycopeptide resistance in enterococci.
    Gholizadeh Y; Courvalin P
    Int J Antimicrob Agents; 2000 Nov; 16 Suppl 1():S11-7. PubMed ID: 11137403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug-resistant gram-positive pathogens. An update on current microbiological patterns.
    Marchese A; Debbia EA; Bacca D; Balistreri G; Musolino B; Schito GC
    Drugs; 1997; 54 Suppl 6():11-20. PubMed ID: 9474477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of glycopeptide resistance in gram-positive pathogens.
    Courvalin P
    Int J Med Microbiol; 2005 Mar; 294(8):479-86. PubMed ID: 15790292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin-resistant enterococci.
    Moellering RC
    Clin Infect Dis; 1998 May; 26(5):1196-9. PubMed ID: 9597252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enterococci and vancomycin resistance.
    French GL
    Clin Infect Dis; 1998 Aug; 27 Suppl 1():S75-83. PubMed ID: 9710674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycopeptide-resistant enterococci: deciphering virulence, resistance and epidemicity.
    Willems RJ; Bonten MJ
    Curr Opin Infect Dis; 2007 Aug; 20(4):384-90. PubMed ID: 17609597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of the genetic elements responsible for acquired glycopeptide resistance in enterococci.
    Woodford N
    Microb Drug Resist; 2001; 7(3):229-36. PubMed ID: 11759084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and mechanisms of glycopeptide resistance in enterococci.
    Zirakzadeh A; Patel R
    Curr Opin Infect Dis; 2005 Dec; 18(6):507-12. PubMed ID: 16258324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of Vancomycin-Resistant Enterococcus Strains in the West Balkans: A First Report.
    Jakovac S; Bojić EF; Ibrišimović MA; Tutiš B; Ostojić M; Hukić M
    Microb Drug Resist; 2017 Jan; 23(1):122-126. PubMed ID: 27351410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
    Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
    Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of the VITEK 2 system to detect glycopeptide resistance in enterococci.
    van Den Braak N; Goessens W; van Belkum A; Verbrugh HA; Endtz HP
    J Clin Microbiol; 2001 Jan; 39(1):351-3. PubMed ID: 11136798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of a teicoplanin-resistant Enterococcus faecium mutant during an outbreak caused by vancomycin-resistant enterococci with the vanB phenotype.
    Kawalec M; Gniadkowski M; Kedzierska J; Skotnicki A; Fiett J; Hryniewicz W
    J Clin Microbiol; 2001 Dec; 39(12):4274-82. PubMed ID: 11724832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of a new glycopeptide antibiotic (LY333328) against enterococci and other resistant gram-positive organisms.
    Fraise AP; Andrews J; Wise R
    J Antimicrob Chemother; 1997 Sep; 40(3):423-5. PubMed ID: 9338497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activities of the semisynthetic glycopeptide LY191145 against vancomycin-resistant enterococci and other gram-positive bacteria.
    Nicas TI; Mullen DL; Flokowitsch JE; Preston DA; Snyder NJ; Stratford RE; Cooper RD
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2585-7. PubMed ID: 8585753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin-resistant enterococci: mechanisms and clinical observations.
    Gold HS
    Clin Infect Dis; 2001 Jul; 33(2):210-9. PubMed ID: 11418881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin resistance: occurrence, mechanisms and strategies to combat it.
    Boneca IG; Chiosis G
    Expert Opin Ther Targets; 2003 Jun; 7(3):311-28. PubMed ID: 12783569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bacteremia caused by Enterococcus gallinarum with a high level of glycopeptide resistance: 1st documented cases in Argentina].
    Togneri A; Lopardo H; Corso A
    Rev Argent Microbiol; 2003; 35(2):96-9. PubMed ID: 12920991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotypic Characterization of Vancomycin-Resistant Enterococcus spp. In Tertiary Center, Iran.
    Shokouhi S; Darazam IA; Javadi A; Rouhani M; Ghasemnejad M
    Infect Disord Drug Targets; 2017; 17(2):90-94. PubMed ID: 28228089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.